HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Friedman, S. L. Search for Related Content PubMed PubMed Citation Articles by Friedman, S. L. Social Bookmarking                      What's this?

J Biol Chem, Vol. 275, Issue 4, 2247-2250, January 28, 2000

MINIREVIEW
Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury^*

Scott L. Friedman

From the Department of Medicine, Division of Liver Diseases, Mount Sinai School of Medicine, New York, New York 10029

	INTRODUCTION

TOP INTRODUCTION Background, Disease Context of... Hepatic Stellate Cells,... Hepatic Stellate Cell... Resolution of Liver Fibrosis... Concluding Remarks REFERENCES

Encapsulation of injury with fibrosis is a highly evolved response of adult tissues. In liver, the components of the process have been greatly clarified, leading to a coherent view of how wound healing occurs in response to injury. Hepatic fibrogenesis provides an important biological and clinical context for emerging concepts in molecular biochemistry that is relevant to many other tissues.

	Background, Disease Context of Hepatic Fibrosis

TOP INTRODUCTION Background, Disease Context of... Hepatic Stellate Cells,... Hepatic Stellate Cell... Resolution of Liver Fibrosis... Concluding Remarks REFERENCES

Chronic injury leading to fibrosis in liver occurs in response to a variety of insults, including viral hepatitis (especially hepatitis B and C), alcohol abuse, drugs, metabolic diseases due to overload of iron or copper, autoimmune attack of hepatocytes or bile duct epithelium, or congenital abnormalities (1). Typically, injury is present for months to years before significant scar accumulates, although the time course may be accelerated in congenital liver disease. Liver fibrosis is reversible, whereas cirrhosis, the end-stage consequence of fibrosis, is generally irreversible. Thus, efforts to understand fibrosis focus primarily on events that lead to the early accumulation of scar in hopes of identifying therapeutic targets to slow its progression.

Like other parenchyma, the normal liver contains an epithelial component (hepatocytes), an endothelial lining (which in liver is distinguished by fenestrae or pores), tissue macrophages (Kupffer cells), and a perivascular mesenchymal cell called the stellate cell (previously called Ito cell, lipocyte, perisinusoidal cell, or fat-storing cell) (Fig. 1); stellate cells are the key fibrogenic cell (see next section). The cellular elements of liver are organized within the sinusoid, or microvascular unit, with the subendothelial space of Disse separating the epithelium (hepatocytes) from the sinusoidal endothelium. In normal liver this space contains a basement membrane-like matrix, although it is not electron-dense like a typical basement membrane. The normal subendothelial extracellular matrix (ECM)¹ is essential for maintaining the differentiated function of all resident liver cells. Establishing the importance of the normal ECM in liver has illuminated recent attempts to develop artificial liver support by recognizing that all cellular elements and supporting structures (not just the hepatocyte compartment) must be reconstituted to preserve differentiated function of liver ex vivo (2).

View larger version (84K): [in this window] [in a new window]   Fig. 1.   Sinusoidal events during fibrosing liver injury. Changes in the subendothelial space of Disse and sinusoid as fibrosis develops in response to liver injury include alterations in both cellular responses and extracellular matrix composition. Stellate cell activation leads to accumulation of scar (fibril-forming) matrix. This in turn contributes to the loss of hepatocyte microvilli and sinusoidal endothelial fenestrae, which result in deterioration of hepatic function. Kupffer cell (macrophage) activation accompanies liver injury and contributes to paracrine activation of stellate cells.

As the liver becomes fibrotic, there are both quantitative and qualitative changes in composition of the hepatic ECM. The total content of collagens and noncollagenous components increases 3-5-fold, accompanied by the shift in the type of ECM in subendothelial space from the normal low density basement membrane-like matrix to interstitial type matrix containing fibril-forming collagens.

	Hepatic Stellate Cells, Principal Fibrogenic Cell Type of Liver

TOP INTRODUCTION Background, Disease Context of... Hepatic Stellate Cells,... Hepatic Stellate Cell... Resolution of Liver Fibrosis... Concluding Remarks REFERENCES

Hepatic stellate cells comprise 15% of the total number of resident liver cells. In normal liver they are the principal storage site for retinoids (3). Stellate cells constitute a heterogeneous group of cells that are functionally and anatomically similar but different in their expression of cytoskeletal filaments, their retinoid content, and their potential for ECM production (4).

Stellate cells have an intriguing embryologic origin, with recent evidence suggesting that they are neural crest-derived because they express glial fibrillary acidic protein and nestin (Ref. 5 and references therein). A neural crest origin is further supported by studies in rat neural crest stem cells, which differentiate into myofibroblasts that express smooth muscle -actin (6), a marker of activated stellate cells. These observations raise the possibility of using neural crest-specific promoters to drive transgene expression selectively in stellate cells in vivo and the prospect of reconstituting stellate cells from a neural crest precursor as part of efforts to repopulate liver.

The perivascular orientation and long cytoplasmic processes of stellate cells facilitate their interactions with neighboring cell types. These processes are adjacent to hepatic nerves, which can respond to -adrenergic stimulation with an influx of cytosolic calcium and release of osmolytes (7).

	Hepatic Stellate Cell Activation, a Highly Orchestrated Response to Tissue Injury

TOP INTRODUCTION Background, Disease Context of... Hepatic Stellate Cells,... Hepatic Stellate Cell... Resolution of Liver Fibrosis... Concluding Remarks REFERENCES

Following liver injury of any etiology, hepatic stellate cells undergo a response known as "activation," which is the transition of quiescent cells into proliferative, fibrogenic, and contractile myofibroblasts.

Stellate cell activation is a remarkably pleiotropic yet tightly programmed response occurring in a reproducible sequence (Fig. 2). The organization of stellate cell activation into a defined temporal sequence provides a framework in which cellular events can be placed into a discrete biologic context. Early events have been termed initiation (also referred to as the "preinflammatory" stage). Initiation encompasses rapid changes in gene expression and phenotype that render the cells responsive to cytokines and other local stimuli. Initiation is associated with transcriptional events and induction of immediate early genes. It results from paracrine stimulation due to rapid, disruptive effects of liver injury on the homeostasis of neighboring cells and from early changes in ECM composition. Perpetuation incorporates those cellular events that amplify the activated phenotype through enhanced cytokine expression and responsiveness; this component of activation results from autocrine and paracrine stimulation, as well as from accelerated ECM remodeling.

View larger version (148K): [in this window] [in a new window]   Fig. 2.   Phenotypic features of hepatic stellate cell activation during liver injury and resolution. Following liver injury, hepatic stellate cells (HSC) undergo "activation," which connotes a transition from quiescent vitamin A-rich cells into proliferative, fibrogenic, and contractile myofibroblasts. The major phenotypic changes after activation include proliferation, con- tractility, fibrogenesis, matrix degradation, chemotaxis, retinoid loss, and white blood cell (WBC) chemoattraction. Key mediators underlying these effects are shown. The fate of activated stellate cells during resolution of liver injury is uncertain but may include reversion to a quiescent phenotype and/or selective clearance by apoptosis.

Initiation: Paracrine Stimulation and Transcriptional Events Begin a Cascade of Cellular Responses

Stimuli initiating stellate cell activation derive from injured hepatocytes and neighboring endothelial and Kupffer cells in addition to rapid, subtle changes in ECM composition.

Hepatocytes and Kupffer cells are a potent source of reactive oxygen intermediates (ROI) (8). These compounds exert paracrine stimulation of stellate cells. Moreover, their activity is amplified in vivo by depletion of antioxidants as typically occurs in diseased liver. In cultured stellate cells, conditioned medium from hepatocytes undergoing oxidative stress increases proliferation and collagen synthesis (9). Overexpression in stellate cells of the enzyme cytochrome P4502E1, which generates ROI, stimulates collagen I gene expression; this effect is attenuated by antioxidants (10).

Endothelial cells play a dual role in early stellate cell activation. Injury to sinusoidal endothelial cells stimulates production of a splice variant of cellular fibronectin (EIIIA isoform), which has an activating effect on stellate cells (11). Additionally, endothelial cells convert latent transforming growth factor-1 (TGF-1) to the active, fibrogenic form through the activation of plasmin (12).

Molecular approaches to explore stellate cell gene regulation during early activation have identified differentially up-regulated genes (13-15). An advantage to the stellate cell system in these studies has been the opportunity to analyze "in vivo" gene expression in freshly purified, homogenous cell isolates. These efforts have yielded a transcription factor (13), an adhesion molecule (ICAM-1) (14), and interestingly, the prion protein (15), among others.

One representative effort to identify regulatory genes during early stellate cell activation has resulted in the cloning of a Kruppel-like factor (KLF) zinc finger gene, Zf9/COPEB/GBF (recently renamed "KLF6"). KLF6 mRNA is rapidly induced in liver injury in vivo and in culture (13) and can transactivate genes regulating ECM accumulation (16). At least two other KLF proteins also regulate stellate cell activation. Sp1, the first member of the KLF family, binds more actively to its consensus motif in activated versus quiescent stellate cells (17, 18). Basic transcription element binding protein 1 (BTEB1) mediates the increase in collagen gene expression, which occurs in response to UV radiation or expression of the transcription factor Jun (19).

Perpetuation: Paracrine and Autocrine Cytokine Activity and ECM Remodeling Sustain the Activated Phenotype

Perpetuation of stellate cell activation involves key phenotypic responses mediated by increased cytokine effects and remodeling of ECM (12). Enhanced cytokine responses occurs through multiple mechanisms (12); among these, increased expression of cell membrane receptors and enhanced signaling are especially important (see Ref. 20 for review). In particular, receptor tyrosine kinases (RTKs), which mediate many of the stellate cell's responses to cytokines, are broadly up-regulated during liver injury (21).

Continued ECM remodeling during this phase underlies virtually all cellular responses characterizing progressive liver injury. The low density subendothelial matrix is progressively replaced by one rich in fibril-forming collagen. This fundamental shift in ECM composition affects the behavior of hepatocytes, sinusoidal endothelium, and stellate cells (Fig. 1).

Fibril-forming ECM also accelerates stellate cell activation. These effects are mediated not only through interactions with integrins, the classic ECM receptors, but also through binding to at least one RTK. Several integrins and their downstream effectors have been identified in stellate cells, including ₁₁, ₂₁, _V1 and ₆₄ (20). Recently, a subfamily of receptor tyrosine kinases, discoidin domain receptors (DDRs), has been characterized, which unlike other RTKs signal in response to fibrillar collagens rather than growth factors (22, 23). With the identification of discoidin domain receptor-2 (DDR2) mRNA in stellate cells (21), a mode of matrix-cell interaction in liver has emerged that may explain why fibril-forming matrix (especially collagen type I) provokes activation of stellate cells during sinusoidal fibrosis. Thus, as the subendothelial basement membrane is replaced by fibrillar collagen stellate cell activation may be perpetuated via binding of collagen to the DDR2 receptor (21, 22).

Phenotypic Responses of Activated Stellate Cells

Discrete phenotype responses of stellate cells can be identified as their activation in response to liver injury is perpetuated. These include: (a) proliferation; (b) contractility; (c) fibrogenesis; (d) matrix degradation; (e) chemotaxis; (f) retinoid loss; and (g) cytokine release and white blood cell chemoattraction.

Proliferation-- Increased numbers of stellate cells in injured liver arise in part from local proliferation in response to polypeptide growth factors, most of which signal through receptor tyrosine kinases. Platelet-derived growth factor (PDGF) is the best characterized and most potent among these proliferative factors in hepatic fibrosis. Injury is associated with both increased autocrine PDGF and up-regulation of PDGF receptor (20). Activated PDGF receptor recruits the signaling molecule Ras, followed by activation of the ERK/mitogen-activated protein kinase pathway. Additionally, activation of phosphoinositol 3-kinase is necessary for both mitogenesis and chemotaxis by pathways largely independent of ERK activation (24). The proliferative response to PDGF also requires a sustained intake of extracellular (Ca²⁺) and increased intracellular pH (20). The activities of a PDGF-regulated Na⁺/H⁺ (25) and a Na⁺/Ca⁺ exchanger (26) both increase in rat stellate cells during activation in culture and in CCl₄ liver injury, respectively. This up-regulation is mediated by calcium/calmodulin- and protein kinase C-dependent pathways (25).

Contractility-- Contractility by activated stellate cells represents an important mechanism underlying increased portal resistance during liver injury. The key contractile stimulus toward stellate cells is endothelin-1 (ET-1), which in part is autocrine-derived (27, 28). Up-regulation of ET-1 production is accompanied by increased endothelin-converting enzyme-1, which activates the latent ET-1 (29). ET-1, in addition to its potent contractile effect, also regulates stellate cell proliferation (28, 30).

At least two G-protein-coupled receptors mediate the effects of ET-1. Unlike receptor tyrosine kinases, which are generally induced during activation, ET receptor types A and B are expressed on both quiescent and activated stellate cells (27). However, the relative prevalence of ETA and ETB receptors changes with the cellular activation, and each mediates divergent responses (30). The proliferative effect of ET-1 in quiescent cells correlates with increased Ras/ERK activity, which is blocked with ETA agonists (30). In contrast, the growth inhibitory effect of ET-1 in activated cells is mediated by the ETB receptor (31) via a prostaglandin/cAMP pathway that leads to down-regulation of ERK and c-Jun kinase (JNK) (31).

Fibrogenesis-- TGF-1 is the dominant stimulus to ECM production by stellate cells (see Ref. 12 for references therein). A role for TGF-1 in perpetuating rather than initiating stellate cell activation has been established by examining the behavior of stellate cells in TGF-1 knockout mice with acute liver injury. These animals have markedly reduced collagen accumulation in response to liver injury as expected but still have increased smooth muscle -actin, indicative of stellate cell activation (32).

TGF-1 is increased in experimental and human hepatic fibrosis. There are many sources of this cytokine; however, autocrine expression is most important (see Ref. 33 for review). Transcriptional up-regulation of the TGF-1 gene has been demonstrated in culture-activated stellate cells (16). TGF-1 activity is also enhanced in activated stellate cells through proteolysis of latent TGF-1 into the active cytokine by a urokinase-type plasminogen activator (12). Release and activity of TGF-1 are controlled by a number of intracellular binding proteins (34). A splice variant of latent TGF-1 binding protein, which lacks a proteinase-sensitive hinge, has been identified in stellate cells (35); this could alter the biologic availability of TGF-1 during fibrosis. Enhanced TGF-1 signaling also underlies the response to injury in stellate cells. Increased binding of TGF-1 to its signaling (types I and II) receptors occurs, yet type II receptor mRNA is decreased during stellate cell activation (12, 36).

Up-regulation of collagen synthesis during activation is among the most striking molecular responses of stellate cells to injury and is mediated by both transcriptional and post-transcriptional mechanisms, not all of which can be ascribed to TGF-1. Transcriptional activation of the type I collagen has been extensively characterized (13, 37, 38). In addition, the half-life of collagen (I)1 mRNA increases 20-fold in activated compared with quiescent stellate cells (39). A conserved stem-loop structure at the 5'-end of the collagen (I)1 mRNA mediates this enhanced mRNA stability through an interaction with the 3'-untranslated region (40).

Matrix Degradation-- Changes in matrix protease activity lead to remodeling of the hepatic ECM during liver injury, which both directly and indirectly accelerates stellate cell activation. Stellate cells express virtually all the key components required for matrix degradation (see Refs. 4, 41, and 42 for reviews). In particular they are a key source of matrix metalloproteinase-2 (MMP-2) as well as stromelysin/MMP-3 (41), each of which degrades the normal subendothelial ECM. This degradation of the normal subendothelial ECM hastens its replacement by fibril-forming collagen, which further activates stellate cell growth and MMP-2 production in a positive feedback loop (43, 44). Initial evidence suggests that both of these effects of fibrillar collagen on stellate cells can be mediated by receptor tyrosine kinase DDR2 (45).

Through the up-regulation of tissue inhibitor of metalloproteinase-1 and -2 (TIMP-1 and -2), activated stellate cells can also inhibit the activity of interstitial collagenases, which additionally favors the accumulation of scar (41). Up-regulation of TIMP-1 gene expression requires a high mobility activator protein-1 binding activity, which is absent from quiescent stellate cells; this mode of regulating TIMP-1 gene expression has not previously been described (46).

Stellate Cell Chemotaxis-- The directed migration of activated stellate cells enhances their accumulation in areas of injury. PDGF and monocyte chemotactic protein-1 (MCP-1) have been identified as chemoattractants toward activated but not quiescent stellate cells (24, 47, 48); chemotaxis requires plasminogen activator, presumably to promote matrix degradation as cells advance through ECM (42). Signaling in response to MCP-1 requires phosphoinositol 3-kinase and calcium influx, but unlike in other MCP-1-responsive cell types, its activity in stellate cells is not mediated by the chemokine receptor CCR2, raising the possibility of a novel receptor (47, 49).

Retinoid Loss-- Loss of intracellular vitamin A is a notable feature of stellate cell activation, yet it remains unknown whether retinoid loss is required for stellate cells to activate and which retinoids might accelerate or prevent activation in vivo. The generation of minor metabolites of retinoic acid (RA), 9-cis RA and 9,13-di-cis RA, has been reported in an experimental model of liver fibrosis induced by porcine serum administration (50). These compounds may have a direct link to fibrogenesis because they stimulate the activation of latent TGF-1, thereby increasing its fibrogenic activity.

Cytokine Release and Leukocyte Chemoattraction-- Increased production and/or activity of cytokines are critical for perpetuation of stellate cell activation. Almost all features of stellate cell activation can be attributed to autocrine cytokines (12). ECM in liver is an important reservoir of bound growth factors (12).

Stellate cells can also amplify inflammation through the release of neutrophil and monocyte chemoattractants. Key inflammatory chemokines are colony-stimulating factor and MCP-1 (49, 51). The secretion of MCP-1 is regulated through ₁ integrin stimulation (20). Up-regulation of adhesion molecules accompanying stellate cell activation further amplifies inflammation during liver injury (52).

	Resolution of Liver Fibrosis and the Fate of Activated Stellate Cells

TOP INTRODUCTION Background, Disease Context of... Hepatic Stellate Cells,... Hepatic Stellate Cell... Resolution of Liver Fibrosis... Concluding Remarks REFERENCES

During recovery from acute human and experimental liver injury the number of activated stellate cells decreases as tissue integrity is restored. This raises an intriguing question. What happens to activated stellate cells during resolution? Do they revert to quiescent cells or are they cleared? Recently answers have begun to emerge.

Reversion?-- A key unresolved issue is whether an activated stellate cell can revert to a quiescent state. One stimulus that may control this response is interleukin-10 (IL-10). IL-10 down-regulates inflammation and increases interstitial collagenase activity (53, 54). IL-10 is induced during stellate cell activation (53) providing an autocrine negative feedback signal to limit scar accumulation.

In addition to effects of soluble cytokines, regression of stellate cell activation may be possible by reconstitution of the normal subendothelial ECM. When stellate cells are grown on a basement membrane substratum (Matrigel) they remain quiescent (45).

Apoptosis?-- One potential fate of activated stellate cells is apoptosis (see Ref. 55 for review). Stellate cell apoptosis associated with reduced TIMP-1 expression has been documented during the recovery phase of experimentally induced liver injury (56). Stellate cells also undergo apoptosis during spontaneous activation, in parallel with increased expression of CD95 L (Fas ligand), Bcl-2, and p53 (55).

	Concluding Remarks

TOP INTRODUCTION Background, Disease Context of... Hepatic Stellate Cells,... Hepatic Stellate Cell... Resolution of Liver Fibrosis... Concluding Remarks REFERENCES

Reductionist models of tissue repair have evolved to clarify relationships between individual molecules, yet more complex, physiologic systems reveal tremendous redundancy both in whole animals and culture models. In 3T3 fibroblasts, for example, distinct signaling pathways mediated by different phosphotyrosines of the -PDGF receptor converge on the same set of immediate early genes, albeit to different extents (57). How then does one identify those signaling pathways truly relevant to a specific disease? Use of a system exemplified by hepatic stellate cells, in which cellular behavior is thoroughly tracked both in vivo and in vitro, provides an important advantage. In stellate cells, gene expression and protein secretion are regulated not only in a cell-specific manner but also depend upon the state of cellular activation. Thus, effects of mediators may diverge at different states of cellular activation, possibly reflecting recruitment of different pathways in early versus late liver injury. The stellate cell system, therefore, provides an ideal platform for large-scale gene analysis using cDNA or oligonucleotide microarrays or transcriptional profiling, where relevance to behavior in vivo is almost certain. What is likely to emerge is an even more coherent paradigm for how complex cellular events are integrated to achieve a distinct biologic end point, the encapsulation of tissue injury by scar.

	ACKNOWLEDGEMENTS

The thoughtful critiques of Drs. J. Maher, F. Ramirez, G. Atweh, and P. Frenette are greatly appreciated. I wish to acknowledge the many outstanding contributions of investigators in the field whose work could not be cited because of space constraints.

	FOOTNOTES

^* This minireview will be reprinted in the 2000 Minireview Compendium, which will be available in December, 2000. My work is supported by National Institutes of Health Grants DK37340 and DK56621, by a grant from the Dean's Office of the Mount Sinai School of Medicine, and by the Artzt Family Foundation.

To whom correspondence should be addressed: Box 1123, Rm. 1170 F, Mount Sinai School of Medicine, 1425 Madison Ave., New York, NY 10029. Tel.: 212-659-9501; Fax: 212-849-2574; E-mail: frieds02@doc.mssm.edu.

	ABBREVIATIONS

The abbreviations used are: ECM, extracellular matrix; ROI, reactive oxygen intermediates; TGF-1, transforming growth factor-1; KLF, Kruppel-like factor; RTK, receptor tyrosine kinase; DDR, discoidin domain receptor; PDGF, platelet-derived growth factor; ERK, extracellular signal-regulated kinase; ET-1, endothelin-1; MMP, matrix metalloproteinase; TIMP, tissue inhibitor of metalloproteinase; MCP-1, monocyte chemotactic protein-1; RA, retinoic acid; IL-10, interleukin-10.

	REFERENCES

TOP INTRODUCTION Background, Disease Context of... Hepatic Stellate Cells,... Hepatic Stellate Cell... Resolution of Liver Fibrosis... Concluding Remarks REFERENCES

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				S. J. Myung, J.-H. Yoon, B. H. Kim, J.-H. Lee, E. U. Jung, and H.-S. Lee Heat Shock Protein 90 Inhibitor Induces Apoptosis and Attenuates Activation of Hepatic Stellate Cells J. Pharmacol. Exp. Ther., July 1, 2009; 330(1): 276 - 282. [Abstract] [Full Text] [PDF]

				N. Nasreen, K. A. Mohammed, K. K. Mubarak, M. A. Baz, O. A. Akindipe, S. Fernandez-Bussy, and V. B. Antony Pleural mesothelial cell transformation into myofibroblasts and haptotactic migration in response to TGF-{beta}1 in vitro Am J Physiol Lung Cell Mol Physiol, July 1, 2009; 297(1): L115 - L124. [Abstract] [Full Text] [PDF]

				H. Ikeda, N. Watanabe, I. Ishii, T. Shimosawa, Y. Kume, T. Tomiya, Y. Inoue, T. Nishikawa, N. Ohtomo, Y. Tanoue, et al. Sphingosine 1-phosphate regulates regeneration and fibrosis after liver injury via sphingosine 1-phosphate receptor 2 J. Lipid Res., March 1, 2009; 50(3): 556 - 564. [Abstract] [Full Text] [PDF]

				N. Ferre, M. Martinez-Clemente, M. Lopez-Parra, A. Gonzalez-Periz, R. Horrillo, A. Planaguma, J. Camps, J. Joven, A. Tres, F. Guardiola, et al. Increased susceptibility to exacerbated liver injury in hypercholesterolemic ApoE-deficient mice: potential involvement of oxysterols Am J Physiol Gastrointest Liver Physiol, March 1, 2009; 296(3): G553 - G562. [Abstract] [Full Text] [PDF]

				O. Hauso, B. I. Gustafsson, I. S. Nordrum, and H. L. Waldum The Effect of Terguride in Carbon Tetrachloride-Induced Liver Fibrosis in Rat Experimental Biology and Medicine, November 1, 2008; 233(11): 1385 - 1388. [Abstract] [Full Text] [PDF]

				T. Shimamura, T. Fujisawa, S. R. Husain, M. Kioi, A. Nakajima, and R. K. Puri Novel Role of IL-13 in Fibrosis Induced by Nonalcoholic Steatohepatitis and Its Amelioration by IL-13R-Directed Cytotoxin in a Rat Model J. Immunol., October 1, 2008; 181(7): 4656 - 4665. [Abstract] [Full Text] [PDF]

				G. Maubach, M. C. C. Lim, and L. Zhuo Nuclear Cathepsin F Regulates Activation Markers in Rat Hepatic Stellate Cells Mol. Biol. Cell, October 1, 2008; 19(10): 4238 - 4248. [Abstract] [Full Text] [PDF]

				T. Li, H. Ma, and J. Y. L. Chiang TGF{beta}1, TNF{alpha}, and insulin signaling crosstalk in regulation of the rat cholesterol 7{alpha}-hydroxylase gene expression J. Lipid Res., September 1, 2008; 49(9): 1981 - 1989. [Abstract] [Full Text] [PDF]

				Y. J. Kang Herbogenomics: From Traditional Chinese Medicine to Novel Therapeutics Experimental Biology and Medicine, September 1, 2008; 233(9): 1059 - 1065. [Abstract] [Full Text] [PDF]

				H. Kim, C. J. Booth, A. B. Pinus, P. Chen, A. Lee, M. Qiu, M. Whitlock, P. S. Murphy, and R. T. Constable Induced Hepatic Fibrosis in Rats: Hepatic Steatosis, Macromolecule Content, Perfusion Parameters, and Their Correlations--Preliminary MR Imaging in Rats Radiology, June 1, 2008; 247(3): 696 - 705. [Abstract] [Full Text] [PDF]

				W. I. Hagens, L. Beljaars, D.A. Mann, M. C. Wright, B. Julien, S. Lotersztajn, C. Reker-Smit, and K. Poelstra Cellular Targeting of the Apoptosis-Inducing Compound Gliotoxin to Fibrotic Rat Livers J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 902 - 910. [Abstract] [Full Text] [PDF]

				E. Miyata, M. Masuya, S. Yoshida, S. Nakamura, K. Kato, Y. Sugimoto, T. Shibasaki, K. Yamamura, K. Ohishi, K. Nishii, et al. Hematopoietic origin of hepatic stellate cells in the adult liver Blood, February 15, 2008; 111(4): 2427 - 2435. [Abstract] [Full Text] [PDF]

				S. L. Friedman Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver Physiol Rev, January 1, 2008; 88(1): 125 - 172. [Abstract] [Full Text] [PDF]

				A. C. Melton, R. K. Soon Jr., J. G. Park, L. Martinez, G. W. deHart, and H. F. Yee Jr. Focal adhesion disassembly is an essential early event in hepatic stellate cell chemotaxis Am J Physiol Gastrointest Liver Physiol, December 1, 2007; 293(6): G1272 - G1280. [Abstract] [Full Text] [PDF]

				J. Che, E. S. L. Chan, and B. N. Cronstein Adenosine A2A Receptor Occupancy Stimulates Collagen Expression by Hepatic Stellate Cells via Pathways Involving Protein Kinase A, Src, and Extracellular Signal-Regulated Kinases 1/2 Signaling Cascade or p38 Mitogen-Activated Protein Kinase Signaling Pathway Mol. Pharmacol., December 1, 2007; 72(6): 1626 - 1636. [Abstract] [Full Text] [PDF]

				G. A. Mekonnen, J. IJzer, and H. Nederbragt Tenascin-C in Chronic Canine Hepatitis: Immunohistochemical Localization and Correlation with Necro-Inflammatory Activity, Fibrotic Stage, and Expression of Alpha-Smooth Muscle Actin, Cytokeratin 7, and CD3+ Cells Vet. Pathol., November 1, 2007; 44(6): 803 - 813. [Abstract] [Full Text] [PDF]

				G. Son, Y. Iimuro, E. Seki, T. Hirano, Y. Kaneda, and J. Fujimoto Selective inactivation of NF-{kappa}B in the liver using NF-{kappa}B decoy suppresses CCl4-induced liver injury and fibrosis Am J Physiol Gastrointest Liver Physiol, September 1, 2007; 293(3): G631 - G639. [Abstract] [Full Text] [PDF]

				R. Safadi, E. Zigmond, O. Pappo, Z. Shalev, and Y. Ilan Amelioration of hepatic fibrosis via beta-glucosylceramide-mediated immune modulation is associated with altered CD8 and NKT lymphocyte distribution Int. Immunol., August 13, 2007; (2007) dxm069v1. [Abstract] [Full Text] [PDF]

				M. Zeisberg, C. Yang, M. Martino, M. B. Duncan, F. Rieder, H. Tanjore, and R. Kalluri Fibroblasts Derive from Hepatocytes in Liver Fibrosis via Epithelial to Mesenchymal Transition J. Biol. Chem., August 10, 2007; 282(32): 23337 - 23347. [Abstract] [Full Text] [PDF]

				A. Kaimori, J. Potter, J.-y. Kaimori, C. Wang, E. Mezey, and A. Koteish Transforming Growth Factor-beta1 Induces an Epithelial-to-Mesenchymal Transition State in Mouse Hepatocytes in Vitro J. Biol. Chem., July 27, 2007; 282(30): 22089 - 22101. [Abstract] [Full Text] [PDF]

				J. L. Gardner, S. M. Turner, A. Bautista, G. Lindwall, M. Awada, and M. K. Hellerstein Measurement of liver collagen synthesis by heavy water labeling: effects of profibrotic toxicants and antifibrotic interventions Am J Physiol Gastrointest Liver Physiol, June 1, 2007; 292(6): G1695 - G1705. [Abstract] [Full Text] [PDF]

				N. BERHE, B. L. HALVORSEN, T. E. GUNDERSEN, B. MYRVANG, S. G. GUNDERSEN, and R. BLOMHOFF REDUCED SERUM CONCENTRATIONS OF RETINOL AND {alpha}-TOCOPHEROL AND HIGH CONCENTRATIONS OF HYDROPEROXIDES ARE ASSOCIATED WITH COMMUNITY LEVELS OF S. MANSONI INFECTION AND SCHISTOSOMAL PERIPORTAL FIBROSIS IN ETHIOPIAN SCHOOL CHILDREN Am J Trop Med Hyg, May 1, 2007; 76(5): 943 - 949. [Abstract] [Full Text] [PDF]

				K. Kinoshita, Y. Iimuro, K. Otogawa, S. Saika, Y. Inagaki, Y. Nakajima, N. Kawada, J. Fujimoto, S. L Friedman, and K. Ikeda Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in rats Gut, May 1, 2007; 56(5): 706 - 714. [Abstract] [Full Text] [PDF]

				H. F. Si, J. Li, X. W. Lu, and Y. Jin Suppressive Effects of Leflunomide on Leptin-Induced Collagen I Production Involved in Hepatic Stellate Cell Proliferation Experimental Biology and Medicine, March 1, 2007; 232(3): 427 - 436. [Abstract] [Full Text] [PDF]

				A. Horani, N. Muhanna, O. Pappo, A. Melhem, C. E. Alvarez, S. Doron, W. Wehbi, K. Dimitrios, S. L. Friedman, and R. Safadi Beneficial effect of glatiramer acetate (Copaxone) on immune modulation of experimental hepatic fibrosis Am J Physiol Gastrointest Liver Physiol, February 1, 2007; 292(2): G628 - G638. [Abstract] [Full Text] [PDF]

				S. March, M. Graupera, M. Rosa Sarrias, F. Lozano, P. Pizcueta, J. Bosch, and P. Engel Identification and Functional Characterization of the Hepatic Stellate Cell CD38 Cell Surface Molecule Am. J. Pathol., January 1, 2007; 170(1): 176 - 187. [Abstract] [Full Text] [PDF]

				S. Zheng and A. Chen Disruption of transforming growth factor-beta signaling by curcumin induces gene expression of peroxisome proliferator-activated receptor-{gamma} in rat hepatic stellate cells Am J Physiol Gastrointest Liver Physiol, January 1, 2007; 292(1): G113 - G123. [Abstract] [Full Text] [PDF]

				M. Takeji, T. Moriyama, S. Oseto, N. Kawada, M. Hori, E. Imai, and T. Miwa Smooth Muscle {alpha}-Actin Deficiency in Myofibroblasts Leads to Enhanced Renal Tissue Fibrosis J. Biol. Chem., December 29, 2006; 281(52): 40193 - 40200. [Abstract] [Full Text] [PDF]

				C. Bertolani, P. Sancho-Bru, P. Failli, R. Bataller, S. Aleffi, R. DeFranco, B. Mazzinghi, P. Romagnani, S. Milani, P. Gines, et al. Resistin as an Intrahepatic Cytokine: Overexpression during Chronic Injury and Induction of Proinflammatory Actions in Hepatic Stellate Cells Am. J. Pathol., December 1, 2006; 169(6): 2042 - 2053. [Abstract] [Full Text] [PDF]

				C. G. Lechuga, Z. H. Hernandez-Nazara, E. Hernandez, M. Bustamante, G. Desierto, A. Cotty, N. Dharker, M. Choe, and M. Rojkind PI3K is involved in PDGF-beta receptor upregulation post-PDGF-BB treatment in mouse HSC Am J Physiol Gastrointest Liver Physiol, December 1, 2006; 291(6): G1051 - G1061. [Abstract] [Full Text] [PDF]

				S.-J. Lee, S. Namkoong, Y.-M. Kim, C.-K. Kim, H. Lee, K.-S. Ha, H.-T. Chung, Y.-G. Kwon, and Y.-M. Kim Fractalkine stimulates angiogenesis by activating the Raf-1/MEK/ERK- and PI3K/Akt/eNOS-dependent signal pathways Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2836 - H2846. [Abstract] [Full Text] [PDF]

				R. G. Ruddell, F. Oakley, Z. Hussain, I. Yeung, L. J. Bryan-Lluka, G. A. Ramm, and D. A. Mann A Role for Serotonin (5-HT) in Hepatic Stellate Cell Function and Liver Fibrosis Am. J. Pathol., September 1, 2006; 169(3): 861 - 876. [Abstract] [Full Text] [PDF]

				N Uyama, L Zhao, E Van Rossen, Y Hirako, H Reynaert, D H Adams, Z Xue, Z Li, R Robson, M Pekny, et al. Hepatic stellate cells express synemin, a protein bridging intermediate filaments to focal adhesions Gut, September 1, 2006; 55(9): 1276 - 1289. [Abstract] [Full Text] [PDF]

				M. S. Shafiei and D. C. Rockey The Role of Integrin-linked Kinase in Liver Wound Healing J. Biol. Chem., August 25, 2006; 281(34): 24863 - 24872. [Abstract] [Full Text] [PDF]

				I A Leclercq, C Sempoux, P Starkel, and Y Horsmans Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats Gut, July 1, 2006; 55(7): 1020 - 1029. [Abstract] [Full Text] [PDF]

				W. Boers, S. Aarrass, C. Linthorst, M. Pinzani, R. O. Elferink, and P. Bosma Transcriptional Profiling Reveals Novel Markers of Liver Fibrogenesis: GREMLIN AND INSULIN-LIKE GROWTH FACTOR-BINDING PROTEINS J. Biol. Chem., June 16, 2006; 281(24): 16289 - 16295. [Abstract] [Full Text] [PDF]

				R. Greupink, H. I. Bakker, W. Bouma, C. Reker-Smit, D. K. F. Meijer, L. Beljaars, and K. Poelstra The Antiproliferative Drug Doxorubicin Inhibits Liver Fibrosis in Bile Duct-Ligated Rats and Can Be Selectively Delivered to Hepatic Stellate Cells in Vivo J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 514 - 521. [Abstract] [Full Text] [PDF]

				K. Cheng, Z. Ye, R. V. Guntaka, and R. I. Mahato Enhanced Hepatic Uptake and Bioactivity of Type {alpha}1(I) Collagen Gene Promoter-Specific Triplex-Forming Oligonucleotides after Conjugation with Cholesterol J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 797 - 805. [Abstract] [Full Text] [PDF]

				F. STICKEL and C. H. OSTERREICHER THE ROLE OF GENETIC POLYMORPHISMS IN ALCOHOLIC LIVER DISEASE Alcohol Alcohol., May 1, 2006; 41(3): 209 - 224. [Abstract] [Full Text] [PDF]

				S. Zheng and A. Chen Curcumin suppresses the expression of extracellular matrix genes in activated hepatic stellate cells by inhibiting gene expression of connective tissue growth factor Am J Physiol Gastrointest Liver Physiol, May 1, 2006; 290(5): G883 - G893. [Abstract] [Full Text] [PDF]

				N. C. Henderson, A. C. Mackinnon, S. L. Farnworth, F. Poirier, F. P. Russo, J. P. Iredale, C. Haslett, K. J. Simpson, and T. Sethi Galectin-3 regulates myofibroblast activation and hepatic fibrosis PNAS, March 28, 2006; 103(13): 5060 - 5065. [Abstract] [Full Text] [PDF]

				Z.-Y. Tong and D. R Brigstock Intrinsic biological activity of the thrombospondin structural homology repeat in connective tissue growth factor. J. Endocrinol., March 1, 2006; 188(3): R1 - R8. [Abstract] [Full Text] [PDF]

				M. Roderfeld, R. Weiskirchen, S. Wagner, M.-L. Berres, C. Henkel, J. Grotzinger, A. M. Gressner, S. Matern, and E. Roeb Inhibition of hepatic fibrogenesis by matrix metalloproteinase-9 mutants in mice FASEB J, March 1, 2006; 20(3): 444 - 454. [Abstract] [Full Text] [PDF]

				K. Izumi, D. Kurosaka, T. Iwata, Y. Oguchi, Y. Tanaka, Y. Mashima, and K. Tsubota Involvement of Insulin-like Growth Factor-I and Insulin-like Growth Factor Binding Protein-3 in Corneal Fibroblasts during Corneal Wound Healing Invest. Ophthalmol. Vis. Sci., February 1, 2006; 47(2): 591 - 598. [Abstract] [Full Text] [PDF]

				T. Bernas, G. Gregori, E. K. Asem, and J. P. Robinson Integrating Cytomics and Proteomics Mol. Cell. Proteomics, January 1, 2006; 5(1): 2 - 13. [Abstract] [Full Text] [PDF]

				A. C. Melton, A. Datta, and H. F. Yee Jr. [Ca2+]i-independent contractile force generation by rat hepatic stellate cells in response to endothelin-1 Am J Physiol Gastrointest Liver Physiol, January 1, 2006; 290(1): G7 - G13. [Abstract] [Full Text] [PDF]

				S. Patella, D. J. Phillips, J. Tchongue, D. M. de Kretser, and W. Sievert Follistatin attenuates early liver fibrosis: effects on hepatic stellate cell activation and hepatocyte apoptosis Am J Physiol Gastrointest Liver Physiol, January 1, 2006; 290(1): G137 - G144. [Abstract] [Full Text] [PDF]

				J.-B. Park, J.-K. Lee, S.-J. Park, and K. D. Riew Hypertrophy of Ligamentum Flavum in Lumbar Spinal Stenosis Associated with Increased Proteinase Inhibitor Concentration J. Bone Joint Surg. Am., December 1, 2005; 87(12): 2750 - 2757. [Abstract] [Full Text] [PDF]

				S. M. O'Byrne, N. Wongsiriroj, J. Libien, S. Vogel, I. J. Goldberg, W. Baehr, K. Palczewski, and W. S. Blaner Retinoid Absorption and Storage Is Impaired in Mice Lacking Lecithin:Retinol Acyltransferase (LRAT) J. Biol. Chem., October 21, 2005; 280(42): 35647 - 35657. [Abstract] [Full Text] [PDF]

				E. Titos, J. Claria, A. Planaguma, M. Lopez-Parra, A. Gonzalez-Periz, J. Gaya, R. Miquel, V. Arroyo, and J. Rodes Inhibition of 5-lipoxygenase-activating protein abrogates experimental liver injury: role of Kupffer cells J. Leukoc. Biol., October 1, 2005; 78(4): 871 - 878. [Abstract] [Full Text] [PDF]

				M. Uemura, E. S. Swenson, M. D.A. Gaca, F. J. Giordano, M. Reiss, and R. G. Wells Smad2 and Smad3 Play Different Roles in Rat Hepatic Stellate Cell Function and {alpha}-Smooth Muscle Actin Organization Mol. Biol. Cell, September 1, 2005; 16(9): 4214 - 4224. [Abstract] [Full Text] [PDF]

				D. Li, S. Yea, S. Li, Z. Chen, G. Narla, M. Banck, J. Laborda, S. Tan, J. M. Friedman, S. L. Friedman, et al. Kruppel-like Factor-6 Promotes Preadipocyte Differentiation through Histone Deacetylase 3-dependent Repression of DLK1 J. Biol. Chem., July 22, 2005; 280(29): 26941 - 26952. [Abstract] [Full Text] [PDF]

				M E Guicciardi and G J Gores Apoptosis: a mechanism of acute and chronic liver injury Gut, July 1, 2005; 54(7): 1024 - 1033. [Full Text] [PDF]

				A. Mazzocca, R. Coppari, R. De Franco, J.-Y. Cho, T. A. Libermann, M. Pinzani, and A. Toker A Secreted Form of ADAM9 Promotes Carcinoma Invasion through Tumor-Stromal Interactions Cancer Res., June 1, 2005; 65(11): 4728 - 4738. [Abstract] [Full Text] [PDF]

				J. S. Lee, N. Kang Decker, S. Chatterjee, J. Yao, S. Friedman, and V. Shah Mechanisms of Nitric Oxide Interplay with Rho GTPase Family Members in Modulation of Actin Membrane Dynamics in Pericytes and Fibroblasts Am. J. Pathol., June 1, 2005; 166(6): 1861 - 1870. [Abstract] [Full Text] [PDF]

				J. S. Kang, H. Wanibuchi, K. Morimura, R. Puatanachokchai, E. I. Salim, A. Hagihara, S. Seki, and S. Fukushima Enhancement by Estradiol 3-Benzoate in Thioacetamide-Induced Liver Cirrhosis of Rats Toxicol. Sci., May 1, 2005; 85(1): 720 - 726. [Abstract] [Full Text] [PDF]

				E. Gabele, S. Reif, S. Tsukada, R. Bataller, Y. Yata, T. Morris, L. W. Schrum, D. A. Brenner, and R. A. Rippe The Role of p70S6K in Hepatic Stellate Cell Collagen Gene Expression and Cell Proliferation J. Biol. Chem., April 8, 2005; 280(14): 13374 - 13382. [Abstract] [Full Text] [PDF]

				K. Yoshida, K. Matsuzaki, S. Mori, Y. Tahashi, H. Yamagata, F. Furukawa, T. Seki, M. Nishizawa, J. Fujisawa, and K. Okazaki Transforming Growth Factor-{beta} and Platelet-Derived Growth Factor Signal via c-Jun N-Terminal Kinase-Dependent Smad2/3 Phosphorylation in Rat Hepatic Stellate Cells after Acute Liver Injury Am. J. Pathol., April 1, 2005; 166(4): 1029 - 1039. [Abstract] [Full Text] [PDF]

				A. Mazzocca, S. C. Sciammetta, V. Carloni, L. Cosmi, F. Annunziato, T. Harada, S. Abrignani, and M. Pinzani Binding of Hepatitis C Virus Envelope Protein E2 to CD81 Up-regulates Matrix Metalloproteinase-2 in Human Hepatic Stellate Cells J. Biol. Chem., March 25, 2005; 280(12): 11329 - 11339. [Abstract] [Full Text] [PDF]

				S. Tsukada, J. K. Westwick, K. Ikejima, N. Sato, and R. A. Rippe SMAD and p38 MAPK Signaling Pathways Independently Regulate {alpha}1(I) Collagen Gene Expression in Unstimulated and Transforming Growth Factor-{beta}-stimulated Hepatic Stellate Cells J. Biol. Chem., March 18, 2005; 280(11): 10055 - 10064. [Abstract] [Full Text] [PDF]

				F. Oakley, J. Mann, S. Nailard, D. E. Smart, N. Mungalsingh, C. Constandinou, S. Ali, S. J. Wilson, H. Millward-Sadler, J. P. Iredale, et al. Nuclear Factor-{kappa}B1 (p50) Limits the Inflammatory and Fibrogenic Responses to Chronic Injury Am. J. Pathol., March 1, 2005; 166(3): 695 - 708. [Abstract] [Full Text] [PDF]

				J. Yamate, Y. Machida, M. Ide, M. Kuwamura, T. Kotani, O. Sawamoto, and J. LaMarre Cisplatin-Induced Renal Interstitial Fibrosis in Neonatal Rats, Developing as Solitary Nephron Unit Lesions Toxicol Pathol, February 1, 2005; 33(2): 207 - 217. [Abstract] [Full Text] [PDF]

				S. K. Meurer, L. Tihaa, B. Lahme, A. M. Gressner, and R. Weiskirchen Identification of Endoglin in Rat Hepatic Stellate Cells: NEW INSIGHTS INTO TRANSFORMING GROWTH FACTOR {beta} RECEPTOR SIGNALING J. Biol. Chem., January 28, 2005; 280(4): 3078 - 3087. [Abstract] [Full Text] [PDF]

				S Sanz, J B Pucilowska, S Liu, C M Rodriguez-Ortigosa, P K Lund, D A Brenner, C R Fuller, J G Simmons, A Pardo, M-L Martinez-Chantar, et al. Expression of insulin-like growth factor I by activated hepatic stellate cells reduces fibrogenesis and enhances regeneration after liver injury Gut, January 1, 2005; 54(1): 134 - 141. [Abstract] [Full Text] [PDF]

				L Xu, A Y Hui, E Albanis, M J Arthur, S M O'Byrne, W S Blaner, P Mukherjee, S L Friedman, and F J Eng Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis Gut, January 1, 2005; 54(1): 142 - 151. [Abstract] [Full Text] [PDF]

				E. Wandzioch, A. Kolterud, M. Jacobsson, S. L. Friedman, and L. Carlsson Lhx2-/- mice develop liver fibrosis PNAS, November 23, 2004; 101(47): 16549 - 16554. [Abstract] [Full Text] [PDF]

				J G. Duplantier, L Dubuisson, N Senant, G Freyburger, I Laurendeau, J-M Herbert, A Desmouliere, and J Rosenbaum A role for thrombin in liver fibrosis Gut, November 1, 2004; 53(11): 1682 - 1687. [Abstract] [Full Text] [PDF]

				H. Steiling, M. Muhlbauer, F. Bataille, J. Scholmerich, S. Werner, and C. Hellerbrand Activated Hepatic Stellate Cells Express Keratinocyte Growth Factor in Chronic Liver Disease Am. J. Pathol., October 1, 2004; 165(4): 1233 - 1241. [Abstract] [Full Text] [PDF]

				C. de Lalla, G. Galli, L. Aldrighetti, R. Romeo, M. Mariani, A. Monno, S. Nuti, M. Colombo, F. Callea, S. A. Porcelli, et al. Production of Profibrotic Cytokines by Invariant NKT Cells Characterizes Cirrhosis Progression in Chronic Viral Hepatitis J. Immunol., July 15, 2004; 173(2): 1417 - 1425. [Abstract] [Full Text] [PDF]

				C Thirunavukkarasu, Y Yang, V M Subbotin, S A K Harvey, J Fung, and C R Gandhi Endothelin receptor antagonist TAK-044 arrests and reverses the development of carbon tetrachloride induced cirrhosis in rats Gut, July 1, 2004; 53(7): 1010 - 1019. [Abstract] [Full Text] [PDF]

				M. Bertrand-Philippe, R. G. Ruddell, M. J. P. Arthur, J. Thomas, N. Mungalsingh, and D. A. Mann Regulation of Tissue Inhibitor of Metalloproteinase 1 Gene Transcription by RUNX1 and RUNX2 J. Biol. Chem., June 4, 2004; 279(23): 24530 - 24539. [Abstract] [Full Text] [PDF]

				Y Yang, E M Nemoto, S A K Harvey, V M Subbotin, and C R Gandhi Increased hepatic platelet activating factor (PAF) and PAF receptors in carbon tetrachloride induced liver cirrhosis Gut, June 1, 2004; 53(6): 877 - 883. [Abstract] [Full Text] [PDF]

				C. K. Sung, H. She, S. Xiong, and H. Tsukamoto Tumor necrosis factor-{alpha} inhibits peroxisome proliferator-activated receptor {gamma} activity at a posttranslational level in hepatic stellate cells Am J Physiol Gastrointest Liver Physiol, May 1, 2004; 286(5): G722 - G729. [Abstract] [Full Text] [PDF]

				R. Gao and D. R. Brigstock Connective Tissue Growth Factor (CCN2) Induces Adhesion of Rat Activated Hepatic Stellate Cells by Binding of Its C-terminal Domain to Integrin {alpha}v{beta}3 and Heparan Sulfate Proteoglycan J. Biol. Chem., March 5, 2004; 279(10): 8848 - 8855. [Abstract] [Full Text] [PDF]

				J A Oben, T Roskams, S Yang, H Lin, N Sinelli, M Torbenson, U Smedh, T H Moran, Z Li, J Huang, et al. Hepatic fibrogenesis requires sympathetic neurotransmitters Gut, March 1, 2004; 53(3): 438 - 445. [Abstract] [Full Text] [PDF]

				A. Canbay, A. Feldstein, E. Baskin-Bey, S. F. Bronk, and G. J. Gores The Caspase Inhibitor IDN-6556 Attenuates Hepatic Injury and Fibrosis in the Bile Duct Ligated Mouse J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 1191 - 1196. [Abstract] [Full Text] [PDF]

				C. Yang, M. Zeisberg, J. C. Lively, P. Nyberg, N. Afdhal, and R. Kalluri Integrin {alpha}1{beta}1 and {alpha}2{beta}1 Are the Key Regulators of Hepatocarcinoma Cell Invasion Across the Fibrotic Matrix Microenvironment Cancer Res., December 1, 2003; 63(23): 8312 - 8317. [Abstract] [Full Text] [PDF]

				D. Seth, M. A. Leo, P. H. McGuinness, C. S. Lieber, Y. Brennan, R. Williams, X. M. Wang, G. W. McCaughan, M. D. Gorrell, and P. S. Haber Gene Expression Profiling of Alcoholic Liver Disease in the Baboon (Papio hamadryas) and Human Liver Am. J. Pathol., December 1, 2003; 163(6): 2303 - 2317. [Abstract] [Full Text]

				R. F. Schwabe, R. Bataller, and D. A. Brenner Human hepatic stellate cells express CCR5 and RANTES to induce proliferation and migration Am J Physiol Gastrointest Liver Physiol, November 1, 2003; 285(5): G949 - G958. [Abstract] [Full Text] [PDF]

				L. Vergnes, J. Phan, M. Strauss, S. Tafuri, and K. Reue Cholesterol and Cholate Components of an Atherogenic Diet Induce Distinct Stages of Hepatic Inflammatory Gene Expression J. Biol. Chem., October 31, 2003; 278(44): 42774 - 42784. [Abstract] [Full Text] [PDF]

				T. Yamada, A. Kuno, K. Masuda, K. Ogawa, M. Sogawa, S. Nakamura, T. Ando, H. Sano, T. Nakazawa, H. Ohara, et al. Candesartan, an Angiotensin II Receptor Antagonist, Suppresses Pancreatic Inflammation and Fibrosis in Rats J. Pharmacol. Exp. Ther., October 1, 2003; 307(1): 17 - 23. [Abstract] [Full Text] [PDF]

				C. Yu, F. Wang, C. Jin, X. Huang, D. L. Miller, C. Basilico, and W. L. McKeehan Role of Fibroblast Growth Factor Type 1 and 2 in Carbon Tetrachloride-Induced Hepatic Injury and Fibrogenesis Am. J. Pathol., October 1, 2003; 163(4): 1653 - 1662. [Abstract] [Full Text] [PDF]

				L. E. Nagy Recent Insights into the Role of the Innate Immune System in the Development of Alcoholic Liver Disease Experimental Biology and Medicine, September 1, 2003; 228(8): 882 - 890. [Abstract] [Full Text] [PDF]

				J. T. Fassett, D. Tobolt, C. J. Nelsen, J. H. Albrecht, and L. K. Hansen The Role of Collagen Structure in Mitogen Stimulation of ERK, Cyclin D1 Expression, and G1-S Progression in Rat Hepatocytes J. Biol. Chem., August 22, 2003; 278(34): 31691 - 31700. [Abstract] [Full Text] [PDF]

				B. Tian, L. Han, J. Kleidon, and C. Henke An HSV-TK Transgenic Mouse Model to Evaluate Elimination of Fibroblasts for Fibrosis Therapy Am. J. Pathol., August 1, 2003; 163(2): 789 - 801. [Abstract] [Full Text] [PDF]

				J. P Iredale Cirrhosis: new research provides a basis for rational and targeted treatments BMJ, July 17, 2003; 327(7407): 143 - 147. [Full Text] [PDF]

				J. G. Parkes and D. M. Templeton Effects of Retinol and Hepatocyte-Conditioned Medium on Cultured Rat Hepatic Stellate Cells Ann. Clin. Lab. Sci., July 1, 2003; 33(3): 295 - 305. [Abstract] [Full Text] [PDF]

				F. Oakley, J. Mann, R. G. Ruddell, J. Pickford, G. Weinmaster, and D. A. Mann Basal Expression of I{kappa}B{alpha} Is Controlled by the Mammalian Transcriptional Repressor RBP-J (CBF1) and Its Activator Notch1 J. Biol. Chem., June 27, 2003; 278(27): 24359 - 24370. [Abstract] [Full Text] [PDF]

				A. Chen and L. Zhang The Antioxidant (-)-Epigallocatechin-3-gallate Inhibits Rat Hepatic Stellate Cell Proliferation in Vitro by Blocking the Tyrosine Phosphorylation and Reducing the Gene Expression of Platelet-derived Growth Factor-{beta} Receptor J. Biol. Chem., June 20, 2003; 278(26): 23381 - 23389. [Abstract] [Full Text] [PDF]

				J. Xu, Y. Fu, and A. Chen Activation of peroxisome proliferator-activated receptor-{gamma} contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth Am J Physiol Gastrointest Liver Physiol, June 9, 2003; 285(1): G20 - G30. [Abstract] [Full Text] [PDF]

				N. Maeda, N. Kawada, S. Seki, T. Arakawa, K. Ikeda, H. Iwao, H. Okuyama, J. Hirabayashi, K.-i. Kasai, and K. Yoshizato Stimulation of Proliferation of Rat Hepatic Stellate Cells by Galectin-1 and Galectin-3 through Different Intracellular Signaling Pathways J. Biol. Chem., May 23, 2003; 278(21): 18938 - 18944. [Abstract] [Full Text] [PDF]

				P A Phillips, M J Wu, R K Kumar, E Doherty, J A McCarroll, S Park, R C Pirola, J S Wilson, and M V Apte Cell migration: a novel aspect of pancreatic stellate cell biology Gut, May 1, 2003; 52(5): 677 - 682. [Abstract] [Full Text]

				S. Reif, A. Lang, J. N. Lindquist, Y. Yata, E. Gabele, A. Scanga, D. A. Brenner, and R. A. Rippe The Role of Focal Adhesion Kinase-Phosphatidylinositol 3-Kinase-Akt Signaling in Hepatic Stellate Cell Proliferation and Type I Collagen Expression J. Biol. Chem., February 28, 2003; 278(10): 8083 - 8090. [Abstract] [Full Text] [PDF]

				P A Phillips, J A McCarroll, S Park, M-J Wu, R Pirola, M Korsten, J S Wilson, and M V Apte Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover Gut, February 1, 2003; 52(2): 275 - 282. [Abstract] [Full Text] [PDF]

				J. Davaille, L. Li, A. Mallat, and S. Lotersztajn Sphingosine 1-Phosphate Triggers Both Apoptotic and Survival Signals for Human Hepatic Myofibroblasts J. Biol. Chem., September 27, 2002; 277(40): 37323 - 37330. [Abstract] [Full Text] [PDF]

				J. G. Simmons, J. B. Pucilowska, T. O. Keku, and P. K. Lund IGF-I and TGF-beta 1 have distinct effects on phenotype and proliferation of intestinal fibroblasts Am J Physiol Gastrointest Liver Physiol, September 1, 2002; 283(3): G809 - G818. [Abstract] [Full Text] [PDF]

				R. G. Crystal, P. B. Bitterman, B. Mossman, M. I. Schwarz, D. Sheppard, L. Almasy, H. A. Chapman, S. L. Friedman, T. E. King Jr., L. A. Leinwand, et al. Future Research Directions in Idiopathic Pulmonary Fibrosis: Summary of a National Heart, Lung, and Blood Institute Working Group Am. J. Respir. Crit. Care Med., July 15, 2002; 166(2): 236 - 246. [Abstract] [Full Text] [PDF]

				D A Mann and D E Smart Transcriptional regulation of hepatic stellate cell activation Gut, June 1, 2002; 50(6): 891 - 896. [Abstract] [Full Text] [PDF]

This Article Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Friedman, S. L. Search for Related Content PubMed PubMed Citation Articles by Friedman, S. L. Social Bookmarking                      What's this?